During the past decade, University of Kansas Medical Center Research Institute, Inc. conducted 54 clinical trials. In the 10-year time frame, 54 clinical trials started and 20 clinical trials were completed, i.e. on average, 37% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 19 clinical trials were completed. i.e. 70.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Kansas Medical Center Research Institute, Inc." #1 sponsor was "Biogen" with 5 trials, followed by "Gilead Sciences" with 3 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Takeda" with 3 trials sponsored and "AtriCure, Inc." with 3 trials sponsored. Other sponsors include 37 different institutions and companies that sponsored additional 44 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Kansas Medical Center Research Institute, Inc." #1 collaborator was "University of Kansas Medical Center" with 3 trials as a collaborator, "Takeda Development Center Americas, Inc." with 2 trials as a collaborator, "Allina Health System" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator and "Brigham and Women's Hospital" with 1 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 38 trials.

According to Clinical.Site data, the most researched conditions in "University of Kansas Medical Center Research Institute, Inc." are "Alzheimer's Disease" (3 trials), "Atrial Fibrillation" (3 trials), "Heart Failure" (3 trials), "Cystic Fibrosis" (2 trials) and "Depressive Disorder, Major" (2 trials). Many other conditions were trialed in "University of Kansas Medical Center Research Institute, Inc." in a lesser frequency.

Most popular intervention types in "University of Kansas Medical Center Research Institute, Inc." are "Drug" (37 trials), "Device" (12 trials), "Biological" (5 trials), "Other" (5 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Aducanumab" (2 trials), "Aticaprant" (2 trials), "Cytarabine" (2 trials) and "IGIV-C" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Kansas Medical Center Research Institute, Inc." are 55 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Kansas Medical Center Research Institute, Inc.". undefined are not yet recruiting, 14 are recruiting, 10 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 21 completed trials in University of Kansas Medical Center Research Institute, Inc., undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in University of Kansas Medical Center Research Institute, Inc., 7 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 9 trials that are defined as “Not Applicable".